Identification and management of cardiopulmonary risk in patients with chronic obstructive pulmonary disease: a multidisciplinary consensus and modified Delphi study - Summary - MDSpire

Identification and management of cardiopulmonary risk in patients with chronic obstructive pulmonary disease: a multidisciplinary consensus and modified Delphi study

  • By

  • Chris P Gale

  • John R Hurst

  • Nathaniel M Hawkins

  • Jean Bourbeau

  • MeiLan K Han

  • Carolyn S P Lam

  • Darcy D Marciniuk

  • David Price

  • Daiana Stolz

  • Ty Gluckman

  • Shelley Zieroth

  • Ramesh Nadarajah

  • Robert P Young

  • Dave Singh

  • Fernando J Martinez

  • David D Berg

  • Mohit Bhutani

  • the Global Working Group on Cardiopulmonary Risk

  • Amr Abdin

  • Dzifa Ahadzi

  • Albert B Albay

  • Bernardino Alcázar Navarrete

  • Luís Alves

  • Sameera Ansari

  • Antonio Anzueto

  • Felix Barasa

  • David D Berg

  • Andy Bevan

  • Mohit Bhutani

  • Giuseppe Biondi-Zoccai

  • Jean Bourbeau

  • Raffaele Bugiardini

  • Daniela Calderaro

  • Arturo Cortes-Telles

  • Michael G Crooks

  • Diego F Echazarreta

  • Nabil Farag

  • Fredrico L A Fernandes

  • Frits M E Franssen

  • Suzanne Fredericks

  • Chris P Gale

  • Olga M García Morales

  • Maria C Gaviria

  • Baris Gencer

  • Gonzalo Ernesto Gianella Malca

  • Kari Hanne Gjeilo

  • Ty Gluckman

  • Martha Gulati

  • MeiLan K Han

  • Nathaniel M Hawkins

  • Jeroen M Hendriks

  • John R Hurst

  • Anh-Thu Huynh Dang

  • Majdy M Idrees

  • Tobin Joseph

  • Nadim Kanj

  • Ee Ming Khoo

  • Bruce Kirenga

  • Leonie Klompstra

  • Martha Kyriakou

  • Carolyn S P Lam

  • Bouchra Lamia

  • Le Thi Tuyet Lan

  • Dominik Linz

  • Angela H E M Maas

  • Darcy D Marciniuk

  • Fernando J Martinez

  • Angela Massouh

  • Walter Mattarucco

  • Renata G Mendes

  • Anant Mohan

  • Trine Moholdt

  • Majid Mokhtari

  • Felicia Montero-Arias

  • Claudia Münks-Lederer

  • Shigeo Muro

  • Ramesh Nadarajah

  • Kazuhiro Nakao

  • Yoko M Nakao

  • Thu Nguyen Ngoc Phuong

  • Johanna O’Callaghan

  • Demosthenes Panagiotakos

  • Alberto Papi

  • Gerardo Payro

  • Massimo Piepoli

  • Marija Polovina

  • Bogdan A Popescu

  • David Price

  • Hany I Ragy

  • Keerthenan Raveendra

  • Christopher M Reid

  • Catherine Reynolds

  • Antonio Luiz P Ribeiro

  • Richard E K Russell

  • Lavanya Saiva

  • Juliana Salas Segura

  • Julie Sanders

  • Raewyn J Scott

  • Terence Seemungal

  • Dinesh Shrikrishna

  • Sami O Simons

  • Dave Singh

  • Yuanlin Song

  • Daiana Stolz

  • Abirami Subramaniam

  • Yongchang Sun

  • Raj Thakkar

  • Frederik Trinkmann

  • Izabella Uchmanowicz

  • Viola Vaccarino

  • Lowie E G W Vanfleteren

  • Rajesh Vedanthan

  • Tonya Winders

  • Jianhua Wu

  • Robert P Young

  • Jinping Zheng

  • Min Zhou

  • Shelley Zieroth

  • March 3, 2025

  • 0 min

Share

Objective:

To establish consensus on the identification and management of cardiopulmonary risk in patients with chronic obstructive pulmonary disease (COPD) and cardiovascular disease.

Key Findings:
  • Cardiovascular disease is a common comorbidity in COPD, often underdiagnosed and undertreated.
  • Patients with cardiovascular risk factors or symptoms should undergo spirometry to confirm COPD.
  • Management of cardiovascular conditions in COPD patients should follow clinical guidelines.
Interpretation:

The identification and management of cardiopulmonary risk in COPD patients is crucial to prevent exacerbations and improve outcomes, highlighting an unmet public health need.

Limitations:
  • The study does not address the primary prevention of cardiovascular and respiratory diseases.
  • There is a lack of existing guidelines for the identification and management of cardiopulmonary risk in COPD.
Conclusion:

Improving the assessment and management of cardiopulmonary risk in COPD patients can enhance overall health outcomes and reduce the risk of adverse events.

Original Source(s)

Related Content